| Related Articles |
Management of venous thromboembolism in patients with cancer.
J Thromb Haemost. 2018 Sep 23;:
Authors: López-Núñez JJ, Trujillo-Santos J, Monreal M
Abstract
Venous thromboembolism (VTE) is a frequent complication and a major cause of death in patients with cancer. Large population-based studies and disease registry surveys have revealed that around 20% of patients with VTE have active cancer. In these patients, VTE is not only associated with shortened survival, but it also has an impact on quality of life because of chronic, residual symptoms and anxiety from fear of recurrence. However, there is also evidence that bleeding to death is a major complication for some cancer patients receiving anticoagulants to manage their VTE. This article is protected by copyright. All rights reserved.
PMID: 30246407 [PubMed - as supplied by publisher]